Birte Wistinghausen

3PUBLICATIONS
14CO-AUTHORS
Haematological tumoursAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 13, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis.

|Feb 05, 2026
Exploring the role of blinatumomab in pediatric B-lymphoblastic lymphoma (B-LLy).

Kaitlin J Devine, Carol Fries, Birte Wistinghausen

|Jan 01, 2024
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.

Birte Wistinghausen, Keri Toner, Donald A Barkauskas

Pageof 1

Frequent Collaborators

2 joint publications

Michelle L Hermiston

1 joint publications

Keri Toner

1 joint publications

Donald A Barkauskas

1 joint publications

Hannah Kinoshita

1 joint publications

Pamela Chansky

1 joint publications

Carol Fries

1 joint publications

Patrick K Campbell

1 joint publications

Michael D Hogarty

1 joint publications

Rima Jubran

1 joint publications

Ashish R Kumar

Frequent Collaborators

2 joint publications

Michelle L Hermiston

1 joint publications

Keri Toner

1 joint publications

Donald A Barkauskas

1 joint publications

Hannah Kinoshita

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on : Mar 25, 2016

15.9K
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on : Sep 07, 2022

2.5K
See more related videos

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on : Mar 25, 2016

15.9K
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on : Sep 07, 2022

2.5K
See more related videos